FOS and central nervous system cancer: In human glioma cells lacking PTEN, reintroduction of wild-type PTEN, inhibition of PI3-kinase by LY294002, or inhibition of AP-1 activity by dominant-negative JUN and FOS resulted in potent downregulation of PDPN expression.